SLC52A3 Knockout HCT 116 Cell Line
Cat.No.:
EDC07753
Species:
Human
Cell Name:
HCT 116
Gene:
SLC52A3
Gene ID:
113278
Size:
1×10⁶cells
SLC52A3 Knockout HCT116 Cell Line is an exclusive upgraded CRISPR/Cas9 system-mediated gene knockout cell, with the advantages of Optimized Strategy Design, Efficient Cell Transfection, High-Performotion Cas9 Protein and Hassle-Free Cell Selection.
| Cat.No. | EDC07753 |
|---|---|
| Product Name | SLC52A3 Knockout HCT116 Cell Line |
| Species | Human |
| Cell Line | HCT 116 |
| Cellosaurus ID | CVCL_0291 |
| Cell Line Synonyms | HCT-116, HCT.116, HCT_116, HCT116, HCT116wt, HCT-116/P, HCT-116/parental, CoCL2 |
| Gene ID | |
| Gene | SLC52A3 |
| Gene Synonyms | BVVLS|BVVLS1|C20orf54|RFT2|RFVT3|bA371L19.1|hRFT2 |
| Summary |
This gene encodes a riboflavin transporter protein that is strongly expressed in the intestine and likely plays a role in intestinal absorption of riboflavin. The protein is predicted to have eleven transmembrane domains and a cell surface localization signal in the C-terminus. Mutations at this locus have been associated with Brown-Vialetto-Van Laere syndrome and Fazio-Londe disease. [provided by RefSeq, Mar 2012]
|
| Associated Diseases | Colorectal Carcinoma |
| Digestion Time | 3 min |
| Morphology | Adherent |
| Passage Ratio | 1:8~1:10 |
| Complete Culture Medium | mcCoy5A+10% FBS |
| Freezing Medium | 90% FBS/complete culture medium+10% DMSO |
* For research use only. Not intended for use in humans or animals, including clinical, therapeutic, or diagnostic purposes.
| Loci | STR Info (Sample Cell) Sample Cell Line: HCT 116 | STR Info (Cell bank) Cell Line: HCT 116 | ||||||
| Allele1 | Allele2 | Allele3 | Allele4 | Allele1 | Allele2 | Allele3 | Allele4 | |
| Amelogenin | X | X | ||||||
| CSF1PO | 7 | 10 | 7 | 9 | 10 | 11 | ||
| D2S1338 | 16 | 16 | ||||||
| D3S1358 | 12 | 17 | 18 | 19 | 12 | 18 | 19 | |
| D5S818 | 10 | 11 | 10 | 11 | ||||
| D7S820 | 11 | 12 | 11 | 12 | ||||
| D8S1179 | 10 | 12 | 14 | 15 | 10 | 12 | 14 | 15 |
| D13S317 | 10 | 12 | 10 | 12 | ||||
| D16S539 | 11 | 13 | 11 | 12 | 13 | 14 | ||
| D18S51 | 16 | 17 | 16 | 17 | ||||
| D19S433 | 12 | 13 | 12 | |||||
| D21S11 | 29 | 30 | 29 | 30 | ||||
| FGA | 18 | 23 | 18 | 23 | ||||
| Penta D | 9 | 13 | 9 | 13 | ||||
| Penta E | 12 | 13 | 14 | 12 | 13 | 14 | ||
| TH01 | 8 | 9 | 8 | 9 | ||||
| TPOX | 8 | 8 | ||||||
| vWA | 17 | 21 | 22 | 23 | 17 | 21 | 22 | 23 |
| D6S1043 | 13 | |||||||
| D12S391 | 17 | 21 | 22 | |||||
| D2S441 | 11 | 12 | ||||||
* STR authentication data of this cell line matches with that of cell lines sourced from ATCC, DSMZ, JCRB, and RIKEN databases.
Conclusion: The STR identification of this cell is correct.
Conclusion: The STR identification of this cell is correct.
FAQ
Which is better for studying SLC52A3 function, SLC52A3 Knockout HCT 116 Cell Line or SLC52A3 overexpression HCT 116 Cell Line?
The choice depends on whether you are studying SLC52A3 (RFVT3)'s role in riboflavin (vitamin B2) transport or modeling Brown-Vialetto-Van Laere syndrome. The Knockout line is the standard tool for asking whether RFVT3 is required for cellular riboflavin uptake — RFVT3 is the principal apical riboflavin transporter in intestine. Overexpression is useful for transport kinetics studies and for testing therapeutic riboflavin supplementation strategies.
For riboflavin biology research, the EDITGENE SLC52A3 Knockout in HCT 116 is particularly relevant for intestinal riboflavin absorption studies — HCT 116 has an intestinal epithelial origin. SLC52A3 mutations cause Brown-Vialetto-Van Laere syndrome type 2 (motor neuron disease responsive to riboflavin supplementation) — disease variant rescue enables genotype-function studies. Rescue with wild-type or transport-deficient RFVT3 is the standard specificity control.
What are the application scenarios for this model?
Primary applications:
• Riboflavin uptake: ³H-riboflavin uptake assays to quantify RFVT3-dependent cellular vitamin B2 acquisition.
• Disease modeling: rescue with Brown-Vialetto-Van Laere syndrome type 2-associated SLC52A3 mutations for genotype-function studies.
• Therapeutic riboflavin response: testing whether high-dose riboflavin can rescue functions in cells expressing specific BVVL mutants.
• RFVT paralog studies: SLC52A1 (RFVT1) and SLC52A2 (RFVT2) expression analysis to interpret intestinal riboflavin transport network.
EDITGENE recommends this model for researchers investigating riboflavin biology, Brown-Vialetto-Van Laere syndrome, and intestinal vitamin B2 absorption.
Is this SLC52A3 Knockout HCT 116 Cell Line compatible with overexpression rescue experiments?
Yes. RFVT3 rescue experiments are well-established for riboflavin biology research:
• Construct design: use a codon-modified SLC52A3 sequence with a small C-terminal tag (FLAG, HA). The 11 transmembrane SLC52 architecture must be preserved.
• BVVL mutation rescue: introduction of patient-derived SLC52A3 mutations enables disease genotype-function correlation in a controlled background.
• Therapeutic riboflavin testing: rescue with disease variants combined with high-dose riboflavin treatment models the clinical therapeutic response.
• Functional readout: rescue should restore ³H-riboflavin uptake activity.
HCT 116 transduces efficiently with lentivirus and is appropriate for intestinal riboflavin absorption studies.
* Research Use Disclaimer: Content is generated from publicly available research data, bioinformatic resources, and computational analyses for research reference only.
download